Many diseases remain undruggable with current therapeutic modalities. Nearly all diseases are driven by genetic mutations. NeuBase is advancing first-in-class precision genetic medicines to “drug the genome” and address disease at its base level to help millions of patients, who currently have no therapeutic options.

NeuBase’s website has been revamped to showcase its advanced technology aimed at tackling various diseases on the PATrOL platform. Our team designed interactive mechanism of action diagrams for each of the three pipeline elements, providing a clear understanding of how the drug candidates interact with targeted mutations. In addition, the website features a patient portal that offers resources to help individuals navigate their journey with the targeted diseases, along with a publication library that provides supporting evidence. It’s an exciting development that brings hope to those who need it most.